Subscribe to Drug Discovery & Development Articles

The Lead

Promising Malaria and Dengue Vaccines Will Not Defeat Diseases

May 20, 2015 | by Christopher J. Pace, Ph.D., GlobalData Managing Analyst, Infectious Diseases | Comments

Some industry pundits rightfully question the modest protective efficacies of CYD-TDV and RTS,S/AS01. Read more...

View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Computing Power vs. Usability – If They Don’t Use It, It’s Not Useful

August 27, 2015 10:04 am | by Trish Meek, Director of Product Strategy, Thermo Fisher Scientific | Comments

Since information technology first went mainstream in laboratories decades ago, many believe that the primary limiting factor on its value has been raw computing power. In the past several years, however, cloud computing and the availability of infrastructure-as-a-service (IaaS), for example, have lowered the cost of computing power so much so that bandwidth and database size are considered commodities. Read more...


Molecular Imaging and its Impact on Drug Development

August 17, 2015 10:44 am | by Dustin Kentala, Associate Study Director in Molecular Imaging, MPI Research | Comments

With the success rates in clinical development from Phase 2 to 3 at 39 percent, preclinical and clinical development teams are implementing alternatives to traditional paradigms to improve efficiency, success, and reduce cost. Read more...


Schizophrenia and Omega-3 Supplement Study Has “Enormous Potential,” Says NIMH Director

August 14, 2015 9:47 am | by Cynthia Fox, Science Editor | Comments

A mere 12 weeks of taking omega-3 fish oil capsules can ward off schizophrenia and other psychoses in at-risk children for 6.7 years, suggests a new Nature Communications paper. Of 41 at-risk young people taking three months of omega-3 supplements, most not only did not show severe functional impairment, but no longer experienced warning signs of psychosis, nearly seven years later. Read more...


Patient-Reported Outcomes in Cancer Drug Development

August 13, 2015 11:34 am | by Stephanie Guzowski, Editor | Comments

When it comes to balancing the risks with the benefits of a drug, it’s vital to have the full picture of a patient’s treatment experience. In an effort to give patients a stronger voice, researchers have created and implemented a system to enable patients to directly report their symptoms during cancer drug development, according to a study published in JAMA Oncology. Read more...


A Single Germline Stem Cell “Switch” May be Anti-Aging Drug Target

August 11, 2015 3:50 pm | by Cynthia Fox, Science Editor | Comments

Aging is not gradual in the C. elegans roundworm. It begins suddenly at reproductive maturity (or roundworm puberty), according to a provocative new study in Molecular Cell by a Northwestern University team. Read more...


Vitamin Supplement May Prolong Onset of Psychosis

August 11, 2015 11:00 am | by Ryan Bushey, Associate Editor | Comments

Results from this study were published today in the journal Nature Communications. Read more...


Searching for a Functional Cure for HIV

August 6, 2015 10:11 am | by Lindsay Hock, Editor | Comments

In 2014, more than 1.2 million people in the U.S. were noted by the Centers for Disease Control and Prevention (CDC) as living with HIV infection. Almost one in eight, or 12.8 percent, are unaware of their infection. The CDC estimates that 1,218,400 person aged 13 and older are living with HIV infection, including 156,300 who are unaware of their infection. Read more...


AstraZeneca Optimistic About Psoriasis Drug Despite Suicide Risks

August 4, 2015 11:32 am | by Ryan Bushey, Associate Editor | Comments

Brodalumab is considered to be a potential blockbuster therapy. Read more...


Oncology Treatment Offers Significant Opportunities with Largest Pharmaceutical Pipeline

August 4, 2015 9:43 am | by Dominic Trewartha, Managing Analyst, GBI Research | Comments

The oncology drug pipeline is far larger than any other therapy area across the pharmaceutical industry. Read more...


Merck's Ebola Vaccine Declared 'Highly Effective' in Clinical Trial

August 3, 2015 9:11 am | by Ryan Bushey, Associate Editor | Comments

Scientists taking part in the investigation tested the drug on 4,000 people with close ties to Ebola patients. Read more...


Beyond Pills: Designing a Winning Delivery Strategy for the New Era of Biologics

July 31, 2015 9:32 am | by Nurry Hong, Managing Director; Sue St. Sure, Managing Director; and Max Cambras, Life Sciences Expert, Manager, of L.E.K. Consulting | Comments

With the rise of biologics, drug delivery presents new challenges as many companies are still taking a fragmented approach, resulting in delayed (or suboptimal) product launches and life cycle management. The problem is that it’s extremely difficult, if not impossible, to fix drug delivery challenges after the fact, so companies need a clear strategy in advance. Read more...


Type 2 Diabetes Mellitus Treatment Market Value Will Reach $39B by 2021

July 31, 2015 9:31 am | by Fiona Chisholm, Associate Analyst, GBI Research | Comments

More recently approved drug classes have already achieved considerable uptake and are expected to increase their market share over the forecast period. Read more...


Teva's $40.5B Allergan Acquisition Likely to Yield Substantial Returns

July 31, 2015 8:40 am | by Gianfranco Zeppetelli, Deals Analyst, GlobalData | Comments

Teva's bid for Allergan’s generics business illustrates that it has given up on its pursuit of rival Mylan NV. Read more...


Gene Therapy Makes Near-Blind Patients See by Strengthening Neural Connections

July 29, 2015 10:13 am | by Cynthia Fox, Science Editor | Comments

Gene therapy restored vision to blind patients by strengthening visual pathways from the retina, through the brain’s white matter, into the brain’s visual cortex, says a report in Science Translational Medicine. Read more...


Four-Pronged Flu Prevention

July 29, 2015 9:39 am | by Lindsay Hock, Editor | Comments

Now, (July/August) is the time frame when flu vaccines start to be delivered to protect the public for next year. Yet, the road to an efficient vaccine is a difficult one. Just as with any virus, influenza mutates in its genetic material, potentially causing changes in the strains present each year. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.